This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Abbvie Stemcentrx LLC. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations of Luis Antonio Cano
Introduction
Luis Antonio Cano is an accomplished inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. His work focuses on innovative methods that enhance the efficacy of treatments for proliferative disorders.
Latest Patents
Luis Antonio Cano holds 1 patent for his invention titled "Site-specific antibody conjugation methods and compositions." This patent provides novel antibody drug conjugates (ADCs) and outlines methods for using these ADCs to treat various proliferative disorders. His innovative approach aims to improve therapeutic outcomes for patients.
Career Highlights
Cano is currently employed at AbbVie Stemcentrx LLC, where he continues to advance his research and development efforts. His work at AbbVie has positioned him as a key player in the biotechnology sector, contributing to the company's mission of delivering innovative therapies.
Collaborations
Throughout his career, Luis has collaborated with notable colleagues, including William Robert Arathoon and Ishai Padawer. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Luis Antonio Cano exemplifies the spirit of innovation in biotechnology through his groundbreaking work on antibody drug conjugates. His contributions are paving the way for more effective treatments for proliferative disorders, showcasing the impact of dedicated inventors in the medical field.